HomeLatest NewsFederal NewsCMS’ proposed rule would lower Medicare Advantage and Part D drug prices

CMS’ proposed rule would lower Medicare Advantage and Part D drug prices

The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule that would provide Medicare Advantage and Part D plans more tools to negotiate lower drug prices. In addition, CMS is considering a policy that would require pharmacy rebates to be passed on to seniors to lower their drug costs at the pharmacy counter.

The proposal would also:

  • Provide Part D plans with greater flexibility to negotiate discounts for drugs in “protected” therapeutic classes, so beneficiaries who need these drugs will see lower costs;
  • Require Part D plans to increase transparency and provide enrollees and their doctors with a patient’s out-of-pocket cost obligations for prescription drugs when a prescription is written;
  • Codify a policy similar to the one implemented for 2019 to allow “step therapy” in Medicare Advantage for Part B drugs, encouraging access to high-value products including biosimilars; and
  • Implement a statutory requirement, recently signed by President Trump, that prohibits pharmacy gag clauses in Part D.

CMS will accept comments on the proposed rule through Jan. 25.

Stay Connected

Unified Voice Newsletter

Events This Month

april

16aprAll Day182024 OneLab Summit

16apr9:00 am10:00 amPalliative Care & Advance Care PlanningSDAHO Webinar

16apr11:00 am12:00 pmIncreasing Revenue and Patient SatisfactionAblePay Webinar

16apr11:00 am1:30 pmLiving with Grief: Diagnosis: Prolonged Grief Disorder (member only webinar)SDAHO Webinar

17apr12:00 pm12:45 pmUnite Against Sepsis: Collaborating to Reduce Sepsis Mortality and Improve Care CoordinationTelligen QI Connect


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact